Hepion Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Net Income	-48.93	-45.34	-32.72	-20.36	-12.48	-17.9	-7.51	-17	-22.19	-5.28
Depreciation & Amortization	0.07	0.08	0.09	0.03	0.03	0.02	0.01	0.02	0.02	0
Share-Based Compensation	1.34	2.55	4.67	2.38	0.07	0.23	0.75	0.9	2.12	0.2
Other Operating Activities	6.63	4.61	-3.26	1.77	-0.62	-6.45	-1.45	-0.48	10.39	3.72
Operating Cash Flow	-40.89	-34.96	-31.22	-16.17	-7.57	-15.65	-8.21	-16.56	-9.67	-1.36
Capital Expenditures	-0.01	-0.01	-0.13	-0.09	-0.05	0	0	-0.01	-0.08	-0.02
Acquisitions	0	0	0	0	0	0	0	-0.5	0	0
Investing Cash Flow	-0.01	-0.01	-0.13	-0.09	-0.05	0	0	-0.5	-0.08	-0.02
Share Issuance / Repurchase	4.49	0	82.15	42.88	9.77	1.78	1.18	19.9	0	3.23
Debt Issued / Paid	0	0	-0.18	0.18	-1.12	1.33	0	0	0	-0.1
Other Financing Activities	-	-5.14	-	-	10.05	9.41	-	-	12.5	-0.02
Financing Cash Flow	4.49	-5.14	81.98	43.05	18.71	12.52	1.18	19.9	12.5	3.11
Exchange Rate Effect	0.01	-0.05	0	0	0	0	0	0	0	0
Net Cash Flow	-36.4	-40.16	50.62	26.8	11.09	-3.12	-7.03	2.84	2.75	1.73
Free Cash Flow	-40.9	-34.98	-31.35	-16.25	-7.62	-15.65	-8.21	-16.56	-9.76	-1.38
Free Cash Flow Per Share	-10.30	-9.18	-8.92	-33.58	-74.55	-1701.68	-1187.50	-6854.73	-5022.63	-1204.87

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).